MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Alpha-Synuclein Aggregates in the Olfactory Epithelium of Subjects with Parkinson Disease, Dementia, COVID-19, and in Aged Controls

J. Tomlinson, N. Lengacher, A-K. Jochum, J. Franz, L. Flatz, B. Mollenhauer, C. Stadelmann, J. Woulfe, M. Schlossmacher (Ottawa, Canada)

Meeting: 2025 International Congress

Keywords: Alpha-synuclein, Ataxia: Etiology and Pathogenesis, Olfactory dysfunction

Category: Parkinson's Disease: Disease mechanisms

Objective: We sought to examine whether neuroepithelial structures of the nasal cavity differ between individuals diagnosed with a Lewy body disorder vs those with COVID19 vs age-matched controls. We hypothesized that a-synuclein is upregulated in the olfactory epithelium and may be found aggregated following a viral infection.

Background: Patients with Parkinson disease (PD) and those with dementia with Lewy bodies (DLB) frequently experience chronic loss of their sense of smell (hyposmia/anosmia), which may precede motor signs by >20 years. Subjects infected by SARS-CoV-2 frequently experience transient hyposmia. Previously, we published that neural structures of the anterior olfactory circuit show high levels of a-synuclein expression.

Method: We used immunohistochemistry on paraffin-embedded sections of the nasal cavity collected at autopsy by resection of the cribriform plate. We analyzed sections from 47 adults, including those diagnosed with a Lewy body disorder (PD, DLB; n=7), other neurological diagnosis (Alzheimer’s, PSP, MSA; n=6), or following a fatal COVID19 infection (n=20), and from healthy controls (n=14). Sections were stained with a panel of validated, monoclonal antibodies against misfolded a-synuclein.

Results: We found that select regions and strata of epithelia revealed four distinct types of aggregates, including 1-2 uM-sized punctae found in the cytoplasm of olfactory neurons, within their apical dendrites, and in epithelial cells of submucosal glands. We also identified larger intracellular aggregates within olfactory sensory neurons and large, extracellular deposits situated above the lamina propria, often near epithelium undergoing repair. When quantifying the four types of a-synuclein aggregates in these sections, we detected more in COVID19 cases.

Conclusion: We conclude that a-synuclein aggregates are formed physiologically within the adult neuroepithelium, including mucin-producing epithelial cells, and axons of cranial nerve-1. Our findings suggest that a-synuclein aggregate formation may be involved in innate host defence mechanisms in the nasal cavity.

References: Lengacher et al., Acta Neuropath Comm 2024
Tomlinson et al., J Neural Transm 2017

To cite this abstract in AMA style:

J. Tomlinson, N. Lengacher, A-K. Jochum, J. Franz, L. Flatz, B. Mollenhauer, C. Stadelmann, J. Woulfe, M. Schlossmacher. Alpha-Synuclein Aggregates in the Olfactory Epithelium of Subjects with Parkinson Disease, Dementia, COVID-19, and in Aged Controls [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/alpha-synuclein-aggregates-in-the-olfactory-epithelium-of-subjects-with-parkinson-disease-dementia-covid-19-and-in-aged-controls/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/alpha-synuclein-aggregates-in-the-olfactory-epithelium-of-subjects-with-parkinson-disease-dementia-covid-19-and-in-aged-controls/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley